Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from RBC Capital

RBC Capital Is Feeling Bullish on Atlassian Stock. Here's Why.

Atlassian shares rally on a bullish RBC Capital research note. Here’s why analyst Matthew Hedberg is bullish on TEAM stock.

Barchart

The Number Tesla Stock Bulls Are Really Waiting for This Earnings Season Has Nothing to Do With Cars

Elon Musk promised Optimus production will begin in July. He will deliver the Q2 earnings on July 22, and analysts will be looking for answers.

Barchart

SpaceX Analyst Sees 64% Upside to Stock: ‘Vertical Integration at Civilization Scale’

The highly anticipated SpaceX (NASDAQ:SPCX) IPO was one of the most talked about events in June. A month later, analysts lined up to provide initial coverage on the space stock.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Why SanDisk’s Wild 462% Rally Has Wall Street Divided

Wall Street is split on whether SanDisk is building a long-term AI powerhouse or heading toward a painful correction.

Barchart

Bloom Energy Is Already Up 240% in 2026, but RBC Analysts Still Think It Has Room to Run

The financial services firm maintains its price target, seeing further upside for Bloom.

Barchart

Dear Tesla Stock Fans, Mark Your Calendars for April 2

Tesla is expected to release Q1 deliveries next week, with analysts looking at another potential decline in numbers.

Barchart

Micron Is Raising Its Dividend by a Whopping 30%. Does That Make MU Stock a Buy Here?

Chip firm Micron Technology raised its dividend by 30%. Should you buy the stock now?

Barchart

Read news from The Economist, FT, and more,
with one subscription

Trump Is Giving This Stock a $40 Billion Boost. Should You Buy It Here?

As President Trump gears up to announce a massive project involving GE Vernova, should you buy its stock now?

Barchart

Dear DocuSign Stock Fans, Mark Your Calendars for March 17

Investors closely watch DOCU as it prepares to release its Q4 FY2026 earnings.

Barchart

Can a New CEO Save Workday Stock from the Software Apocalypse?

Workday announced a CEO transition amid fears of AI affecting software businesses.

Barchart

Corteva Stock: Is Wall Street Bullish or Bearish?

Are Wall Street analysts bullish or bearish on Corteva’s stock post its Q4 earnings release?

Barchart

This Analyst Warns Palantir Stock Could Plunge to $50. Should You Sell Shares Now?

RBC Capital analyst explains why Palantir stock runs the risk of a crash to $50. PLTR insiders have also been unloading shares over the past six months.

Barchart

RBC Capital Sees a $550 Billion Reason to Buy These 3 Chip Stocks

The investment bank expects demand for chips to continue to soar.

Barchart

Could 2026 Be the Year Palantir Stock Hits a $1 Trillion Valuation?

Wedbush’s Dan Ives sees Palantir reaching $1 trillion valuation in the future.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Broadcom To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Analyst Sees Value In Neumora's Expanding Obesity And Metabolic Pipeline

RBC Capital Markets upgraded Neumora Therapeutics, Inc. (NASDAQ:NMRA) from Sector Perform to Outperform, with an increased price forecast from $4 to $7.

Benzinga

Amazon To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Applied Materials To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Take-Two Interactive Software To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Wall Street's Most Accurate Analysts Give Their Take On 3 Financial Stocks With Over 10% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga

Nucor To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Qualcomm To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Barchart

100 Stocks to Buy: Is Sunrun Ready to Run Higher?

The solar panel installer’s stock jumped 5% on Monday after RBC Capital increased its target price to $22. RUN moved up five positions in Barchart’s Top 100 Stocks to Buy to the 68th spot. Sunrun looks ready to run higher.

Benzinga

SLB To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Alphabet To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.